UBLITUXIMAB

3894 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC]

These side effects are most commonly reported by patients taking UBLITUXIMAB:

# Side effect Count
0 INFUSION RELATED REACTION 1435
1 FATIGUE 238
2 HEADACHE 124
3 MALAISE 116
4 PAIN 109
5 URINARY TRACT INFECTION 103
6 ILLNESS 100
7 MULTIPLE SCLEROSIS RELAPSE 99
8 ASTHENIA 94
9 GAIT DISTURBANCE 90
See all common reactions for UBLITUXIMAB

UBLITUXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BREAST RADIAL SCAR 1 0.3333
1 ENDOMETRIOSIS SURGICAL REMOVAL 1 0.1250
2 ACUTE FLACCID MYELITIS 1 0.0833
3 INFUSION SITE NERVE DAMAGE 2 0.0625
4 ULTRASOUND FOETAL ABNORMAL 5 0.0595
5 ENDOMETRIAL CANCER STAGE IV 2 0.0541
6 ENTEROVIRUS MYOCARDITIS 1 0.0526
7 CD19 LYMPHOCYTE COUNT ABNORMAL 1 0.0476
8 DESQUAMATIVE INFLAMMATORY VAGINITIS 1 0.0455
9 MENINGITIS HAEMOPHILUS 2 0.0435
See all enriched reactions for UBLITUXIMAB